Growth Hormone Deficiency Market
Growth hormone deficiency is a condition where the pituitary gland is unable to make enough growth hormone. It can be caused by damage to the pituitary gland or another gland called the hypothalamus. The injury can occur before birth (congenital), or during or after birth (acquired). A third category has no known or diagnosable cause (idiopathic). Growth hormone deficiency may be caused by a tumor in the brain. These tumors are normally located at the site of the pituitary gland or the nearby hypothalamus region of the brain. In children and adults, serious head injuries, infections, and radiation treatments can also cause Growth hormone deficiency, which is known as acquired Growth hormone deficiency (AGHD). However, in rare cases, Growth hormone deficiency can be part of a genetic syndrome such as Turner syndrome and Prader-Willi syndrome. Additionally, in many cases, the cause of Growth hormone deficiency is not known or idiopathic.
DelveInsight's "Growth
Hormone Deficiency Market Insights, Epidemiology, and Market
Forecast-2030" report delivers an in-depth understanding of the
Growth Hormone Deficiency, historical and forecasted epidemiology as well as
the Growth Hormone Deficiency market trends in the United States, EU5 (Germany,
Spain, Italy, France, and United Kingdom) and Japan.
Some of Growth
hormone deficiency Market Report Facts are:
·
As per the study by Bonfig et al. (2019) titled
“Mini Review/Commentary: Growth Hormone Treatment in Children with Type 1
Diabetes,” the prevalence of GHD ranges between 1/3500 and 1/8700 in Germany.
·
According to the Boston Children’s Hospital,
about 1 in 4,000–10,000 children have GHD.
·
Several secondary sources suggest that GHD is
slightly more prevalent in males than in females.
·
According to the Growth Hormone Foundation
estimates, more than 50,000 adults in the United States are growth hormone
deficient, and 6,000 new cases are reported each year, including GHD children
who transition to GHD as an adult.
·
It is estimated that in the adult UK population
at any given time, approximately 1 in every 10,000 people will have adult-onset
GHD, which works out to approximately 12,600 adults with GHD in England and
Wales.
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/growth-hormone-deficiency-ghd-market
Some of Growth
hormone deficiency Companies are:
·
Ascendis Pharma
·
Pfizer
·
Opko
·
Lumos Pharma
·
Novo Nordisk
·
Ipsen
·
Pfizer
·
And Many Others
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/growth-hormone-deficiency-ghd-market
Scope of the Growth
hormone deficiency Report:
- The
report covers the descriptive overview of Growth Hormone Deficiency,
explaining its causes, signs and symptoms, pathophysiology, diagnosis and
currently available therapies
- Comprehensive
insight has been provided into the Growth Hormone Deficiency epidemiology
and treatment in the 7MM
- Additionally,
an all-inclusive account of both the current and emerging therapies for
Growth Hormone Deficiency are provided, along with the assessment of new
therapies, which will have an impact on the current treatment landscape
- A
detailed review of Growth Hormone Deficiency market; historical and
forecasted is included in the report, covering drug outreach in the 7MM
- The
report provides an edge while developing business strategies, by
understanding trends shaping and driving the global Growth Hormone
Deficiency market
Some of Growth
hormone deficiency therapies are:
·
TransCon hGH
·
Somatrogon
·
LUM-201
·
Norditropin
·
Sogroya (somapacitan)
·
Increlex
·
Genotropin
·
And Many Others
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/growth-hormone-deficiency-ghd-market
Table of Contents:
1. Key Insights
2. Executive Summary
of Growth Hormone Deficiency
3. Competitive
Intelligence Analysis for Growth Hormone Deficiency
4. Growth Hormone
Deficiency: Market Overview at a Glance
5. Growth Hormone
Deficiency: Disease Background and Overview
6. Patient Journey
7. Growth Hormone
Deficiency Epidemiology and Patient Population
8. Treatment
Algorithm, Current Treatment, and Medical Practices
9. Unmet Needs
10. Key Endpoints of
Growth Hormone Deficiency Treatment
11. Marketed
Products
List to be continued in report
12. Emerging
Therapies
List to be continued in report
13. Growth Hormone
Deficiency: Seven Major Market Analysis
14. Attribute
analysis
15. 7MM: Market
Outlook
16. Access and
Reimbursement Overview of Growth Hormone Deficiency
17. KOL Views
18. Market Drivers
19. Market Barriers
20. Appendix
21. DelveInsight
Capabilities
22. Disclaimer
23. About
DelveInsight
Request for Detailed
TOC: https://www.delveinsight.com/sample-request/growth-hormone-deficiency-ghd-market
Other Links:
·
Electrophysiology
Devices Market
·
Growth
Hormone Deficiency Market
·
Interventional
Neuroradiology Market
·
Intracranial
Pressure Monitoring Devices Market
·
Foot and Ankle Devices Market
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research Firm focused
exclusively on life sciences. It supports pharma companies by providing
end-to-end comprehensive solutions to improve their performance.
Contact us
Ankit Nigam
info@delveinsight.com
+91-9650213330
https://www.delveinsight.com/
Connect With Us at:
LinkedIn | Facebook | Twitter
Request for Free
Sample Report: https://www.delveinsight.com/sample-request/growth-hormone-deficiency-ghd-market
Comments
Post a Comment